AptarGroup, Inc. (NYSE:ATR – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 507,500 shares, an increase of 6.9% from the August 31st total of 474,600 shares. Based on an average trading volume of 274,100 shares, the short-interest ratio is presently 1.9 days.
Analysts Set New Price Targets
Separately, Wells Fargo & Company upped their price objective on shares of AptarGroup from $163.00 to $168.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th.
View Our Latest Stock Report on AptarGroup
Insider Transactions at AptarGroup
Institutional Trading of AptarGroup
A number of institutional investors have recently added to or reduced their stakes in ATR. Rise Advisors LLC acquired a new stake in shares of AptarGroup during the 1st quarter valued at approximately $25,000. Blue Trust Inc. raised its holdings in AptarGroup by 281.0% during the second quarter. Blue Trust Inc. now owns 240 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 177 shares during the last quarter. Gradient Investments LLC purchased a new stake in AptarGroup during the second quarter worth $40,000. Versant Capital Management Inc grew its holdings in AptarGroup by 4,983.3% in the second quarter. Versant Capital Management Inc now owns 305 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 299 shares during the last quarter. Finally, Mather Group LLC. purchased a new position in shares of AptarGroup in the first quarter valued at $52,000. Hedge funds and other institutional investors own 88.52% of the company’s stock.
AptarGroup Price Performance
Shares of ATR opened at $159.97 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The stock’s 50 day moving average is $149.85 and its two-hundred day moving average is $146.08. AptarGroup has a twelve month low of $120.36 and a twelve month high of $161.55. The firm has a market capitalization of $10.60 billion, a PE ratio of 34.33, a P/E/G ratio of 3.21 and a beta of 0.57.
AptarGroup (NYSE:ATR – Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The industrial products company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.01. The firm had revenue of $910.10 million for the quarter, compared to the consensus estimate of $930.15 million. AptarGroup had a return on equity of 15.13% and a net margin of 9.00%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.23 earnings per share. Research analysts anticipate that AptarGroup will post 5.36 earnings per share for the current year.
AptarGroup Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Thursday, July 25th were issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend was Thursday, July 25th. This is an increase from AptarGroup’s previous quarterly dividend of $0.41. AptarGroup’s dividend payout ratio (DPR) is currently 38.63%.
AptarGroup Company Profile
AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.
Further Reading
- Five stocks we like better than AptarGroup
- ETF Screener: Uses and Step-by-Step Guide
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Plot Fibonacci Price Inflection Levels
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is the Dogs of the Dow Strategy? Overview and Examples
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.